59516
SUPELCOSIL™ LC-NH₂ NP (5 µm) HPLC Columns
L × I.D. 2 cm × 4 mm Supelguard Guard Cartridge pkg of 2 ea, Guard Cartridge holder required for use
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
NB.21
L × i.d.:
2 cm × 4 mm
Particle size:
5 μm
Matrix active group:
NH2, amino phase
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleNombre del producto
Cartucho SUPELCOSIL™ LC-NH2-NP Supelguard, 5 μm particle size, L × I.D. 2 cm × 4 mm
agency
suitable for USP L8
Quality Level
packaging
pkg of 2 ea
technique(s)
HPLC: suitable
L × I.D.
2 cm × 4 mm
matrix active group
NH2, amino phase
particle size
5 μm
application(s)
food and beverages
separation technique
normal phase
Legal Information
SUPELCOSIL is a trademark of Sigma-Aldrich Co. LLC
Still not finding the right product?
Explore all of our products under Cartucho SUPELCOSIL™ LC-NH2-NP Supelguard
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Vijay V Upreti et al.
Biomedical chromatography : BMC, 17(6), 385-390 (2003-09-19)
A simple and sensitive high-performance liquid chromatography (HPLC) method has been developed and validated for the determination of DRF-1042, a novel orally active camptothecin (CPT) analog, in human plasma. The sample preparation was a simple deproteinization with acidified methanol yielding
E M Koves
Journal of chromatography. A, 692(1-2), 103-119 (1995-02-10)
A comprehensive approach to the analysis for many drugs in postmortem blood and biological fluids using high-performance liquid chromatography and diode array detection has been developed. To reduce the likelihood of co-eluting interference components of postmortem blood or other drugs
S Djabarouti et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 799(1), 165-172 (2003-12-09)
The aim of this study was to develop a specific and sensitive high-performance liquid chromatographic (HPLC) assay for the determination of levofloxacin in human plasma, bronchoalveolar lavage and bone tissues. The sample extraction was based on a fully automated liquid-solid